Medical Plastic Injection Molding: Materials, Compliance Risks & When NOT to Use It
Injection molding is often the right choice for repeatable, high-volume production—but in medical programs, the decision is rarely “molding by default.” Material biocompatibility, sterilization aging, and validation cycles can turn standard assumptions into avoidable compliance and quality risk.
This hub is designed as an engineer-friendly decision entry: what to verify first, what changes under ISO 13485-style expectations, where Class-A tooling becomes a liability, and which failure modes are unacceptable for medical parts.
How to evaluate material biocompatibility risks
USP Class / ISO 10993 context, sterilization compatibility, extractables concerns, and lot-to-lot variation controls.
What ISO 13485 changes in tooling & validation
Process traceability, documentation rigor, IQ/OQ/PQ expectations, and validation-driven lead-time realities.
When Class-A tooling becomes a liability
Early R&D, frequent geometry changes, unclear CTQs—hard tooling can lock in cost before design is stable.
Failure modes unacceptable in medical parts
Flash, short shots, sink/voids, stress cracking, particulate risk—plus prevention via gate/venting design and inspection loops.